3. Goutte C, Tsunozaki M, Hale VA, Priess JR (2002) APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc Natl Acad Sci U S A 99: 775–9. 4. Lee SF, Shah S, Li H, Yu C, Han W, et al. (2002) Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch. J Biol Chem 277: 45013–9. 5. Steiner H, Winkler E, Edbauer D, Prokop S, Basset G, et al. (2002) PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. J Biol Chem 277: 39062–5. 6. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, et al. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391: 387–90. 7. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999 398: 518–22. 8. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, et al. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398: 513–7. 9. Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, et al. (2003) The role of presenilin cofactors in the gamma-secretase complex. Nature 422: 438–41. 10. Bitan G, Vollers SS, Teplow DB (2003) Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. J Biol Chem 278: 34882–9. 11. Chen YR, Glabe CG (2006) Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. J Biol Chem 281: 24414–22. 12. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, et al. (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17: 1005–13. 13. Isoo N, Sato C, Miyashita H, Shinohara M, Takasugi N, et al. (2007) Abeta42 overproduction associated with structural changes in the catalytic pore of gamma-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate. J Biol Chem 282: 12388–96. 14. Serneels L, Van Biervliet J, Craessaerts K, Dejaegere T, Horre´ K, et al. (2009) gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer’s disease. Science 324: 639–42. 15. Tesco G, Ginestroni A, Hiltunen M, Kim M, Dolios G, et al. (2005) APP substitutions V715F and L720P alter PS1 conformation and differentially affect Abeta and AICD generation. J Neurochem 95: 446–56. 16. Herl L, Thomas AV, Lill CM, Banks M, Deng A, et al. (2009) Mutations in amyloid precursor protein affect its interactions with presenilin/gamma- secretase. Mol Cell Neurosci 41: 166–74. 17. Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, et al. (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414: 212–6. 18. Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, et al. (2003) NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest 112: 440–9. 19. Kukar TL, Ladd TB, Bann MA, Fraering PC, Narlawar R, et al. (2008) Substrate-targeting gamma-secretase modulators. Nature 453: 925–9. 20. Lleo´ A, Berezovska O, Herl L, Raju S, Deng A, et al. (2004) Nonsteroidal anti- inflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nat Med 10: 1065–6. 21. Berezovska O, Lleo A, Herl LD, Frosch MP, Stern EA, et al. (2005) Familial Alzheimer’s disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J Neurosci 25: 3009–17. PS1 Conformation and Ab 22. Cervantes S, Gonza`lez-Duarte R, Marfany G (2001) Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer’s disease. FEBS Lett 505: 81–6. 23. Schroeter EH, Ilagan MX, Brunkan AL, Hecimovic S, Li YM, et al. (2003) A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis Proc Natl Acad Sci U S A 100: 13075–80. 24. Herl L, Lleo A, Thomas AV, Nyborg AC, Jansen K, et al. (2006) Detection of presenilin-1 homodimer formation in intact cells using fluorescent lifetime imaging microscopy. Biochem Biophys Res Commun 340: 668–74. 25. Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, et al. (2005) Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med 11: 545–50. 26. Bittner T, Fuhrmann M, Burgold S, Jung CK, Volbracht C, et al. (2009) gamma-Secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway. J Neurosci 29: 10405–9. 27. Geling A, Steiner H, Willem M, Bally-Cuif L, Haass C (2002) A gamma- secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep3: 688–94. 28. Annaert WG, Esselens C, Baert V, Boeve C, Snellings G, et al. (2001) Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32: 579–89. 29. Sato C, Takagi S, Tomita T, Iwatsubo T (2008) The C-terminal PAL motif and transmembrane domain 9 of presenilin 1 are involved in the formation of the catalytic pore of the gamma-secretase. J Neurosci 28: 6264–71. 30. Tolia A, Horre´ K, De Strooper B (2008) Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of gamma-secretase. J Biol Chem 283: 19793–803. 31. Lazarov VK, Fraering PC, Ye W, Wolfe MS, Selkoe DJ, et al. (2006) Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores. Proc Natl Acad Sci U S A 103: 6889–94. 32. Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Ozols V, et al. (2003) Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. J Biol Chem 278: 31831–7. 33. Beher D, Clarke EE, Wrigley JD, Martin AC, Nadin A, et al. (2004) Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma- secretase at a novel site. Evidence for an allosteric mechanism. J Biol Chem 279: 43419–26. 34. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, et al. (2000) Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol 2: 461–2. 35. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, et al. (2000) A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 5: 197–206. 36. Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, et al. (1988) Beta- amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A 85: 7341–5. 37. Xia W, Zhang J, Kholodenko D, Citron M, Podlisny MB, et al. (1997) Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem 272: 7977–82. 38. Saffarian S, Kirchhausen T (2008) Differential evanescence nanometry: live-cell fluorescence measurements with 10-nm axial resolution on the plasma membrane. Biophys J 94: 2333–42. PLoS ONE | www.plosone.org 9 November 2009 | Volume 4 | Issue 11 | e7893